Hypertension, Vol 7, 438-442, Copyright © 1985 by American Heart Association
FC Luft, GR Aronoff, RS Sloan, NS Fineberg and MH Weinberger
To test the hypothesis that the antihypertensive effect of the calcium
channel blocking drug nitrendipine is in part related to natriuresis, we
gave 16 subjects (8 normal, 8 hypertensive) placebo for 8 days followed by
nitrendipine titrated to 20 mg twice daily for 8 days. The same diet was
prepared for each meal for the entire study. Sodium intake was fixed for
each subject and averaged 150 mEq/day. All urine was collected every day.
Blood was drawn at the end of the placebo and nitrendipine periods for
renin, aldosterone, and norepinephrine values. Nitrendipine caused a
significant increase (p less than 0.05) in cumulative sodium excretion of
161 mEq over 7 days in the normal subjects and 103 mEq in hypertensive
subjects. Potassium excretion was unaffected. In both hypertensive and
normal subjects, plasma renin and plasma norepinephrine activity increased
significantly (p less than 0.05), while plasma aldosterone levels did not
change. Upright systolic blood pressure decreased significantly (p less
than 0.05) in both groups, whereas upright diastolic blood pressure
decreased only in hypertensive subjects. We conclude that blood pressure
lowering effects of this drug may be in part related to natriuresis and
that calcium channel blockade may dissociate plasma renin activity from
that of aldosterone.
ARTICLES
Calcium channel blockade with nitrendipine. Effects on sodium homeostasis, the renin-angiotensin system, and the sympathetic nervous system in humans
This article has been cited by other articles:
![]() |
H. Kobori, M. Nangaku, L. G. Navar, and A. Nishiyama The Intrarenal Renin-Angiotensin System: From Physiology to the Pathobiology of Hypertension and Kidney Disease Pharmacol. Rev., September 1, 2007; 59(3): 251 - 287. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Shibao, A. Gamboa, R. Abraham, S. R. Raj, A. Diedrich, B. Black, D. Robertson, and I. Biaggioni Clonidine for the Treatment of Supine Hypertension and Pressure Natriuresis in Autonomic Failure Hypertension, March 1, 2006; 47(3): 522 - 526. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. JORDAN, J. R. SHANNON, B. POHAR, S. Y. PARANJAPE, D. ROBERTSON, R.-M. ROBERTSON, and I. BIAGGIONI Contrasting Effects of Vasodilators on Blood Pressure and Sodium Balance in the Hypertension of Autonomic Failure J. Am. Soc. Nephrol., January 1, 1999; 10(1): 35 - 42. [Abstract] [Full Text] |
||||
![]() |
M. C. Houston, M. Weir, J. Gray, D. Ginsberg, C. Szeto, P. M. Kaihlenen, D. Sugimoto, M. Runde, and M. Lefkowitz The Effects of Nonsteroidal Anti-inflammatory Drugs on Blood Pressures of Patients With Hypertension Controlled by Verapamil Arch Intern Med, May 22, 1995; 155(10): 1049 - 1054. [Abstract] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1985 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |